Celebrating MedTech Innovation at the SoCalBio Conference
The Southern California Biomedical Council (SoCalBio) is gearing up for its 27th Annual Investor & Partnership Conference. This exciting event will see prominent MedTech executives sharing valuable insights and experiences. Notable speakers include Murthy Simhambhatla, PhD, President and CEO of SetPoint Medical, and Raymond W. Cohen, a seasoned industry deal-maker.
Keynote Speakers Set to Inspire
At the conference, attendees can look forward to a compelling keynote session from Dr. Simhambhatla. He plans to delve deep into the journey of SetPoint's first-in-class neuroimmune modulation therapy, a groundbreaking treatment for rheumatoid arthritis, which recently received FDA approval. This innovative device targets the vagus nerve, representing a critical shift in how autoimmune diseases are approached.
A Vision for New Treatment Paradigms
Dr. Simhambhatla emphasizes that the goal of their technology goes beyond just treating symptoms; it aims to provide patients with a viable alternative to traditional immunosuppressive drugs. His aspiration is to offer a therapy that helps manage not just rheumatoid arthritis but also other autoimmune conditions, hinting at the vast potential this technology holds.
The Contributions of a MedTech Veteran
The second keynote is scheduled to be presented by Raymond W. Cohen, a veteran CEO with extensive experience in the MedTech industry. His leadership at Axonics paved the way for the company's successful IPO and eventual acquisition by Boston Scientific. With over four decades of experience, Cohen brings valuable insights into the dynamics of building successful medical technology businesses.
Lessons in Success from a Proven Leader
During his talk, Cohen will share lessons learned throughout his career, focusing on the importance of innovative thinking and teamwork. His philosophy underlines that real results in MedTech come from disciplined execution and collaboration.
Collaboration as a Key Ingredient
The conference will also spotlight the significance of international relations in enhancing innovation. Michael Wilmott, Senior Trade Commissioner from the Consulate General of Canada, will discuss how fostering partnerships can benefit U.S. companies looking to expand in the Canadian market. His remarks will precede Dr. Simhambhatla’s keynote, setting an excellent tone for discussions on cooperation in the industry.
Exciting Conference Agenda
The SoCalBio Investor & Partnership Conference isn’t just about keynote speeches; it presents a packed agenda that includes startup presentations and investor panels. Key topics for discussion will range from workforce development to the latest advances in AI technology applied in MedTech solutions.
An Annual Highlight for Biosciences
This event is Southern California’s premier opportunity for bioscience entrepreneurs to connect with investors and strategic partners. It celebrates the advancements in the life sciences sector and aims to pave the way for future innovations.
About SoCalBio
The Southern California Biomedical Council (SoCalBio) plays a vital role as a nonprofit trade association, promoting the growth and development of the bioscience industry across the Greater Los Angeles area. SoCalBio's initiatives support local firms in accessing the resources they need to thrive professionally and economically.
Workshop and Training Opportunities
Beyond its investment-focused events, SoCalBio is committed to facilitating technology transfer and workforce training, aligning with its mission to advocate for the economic impact and benefits of the bioscience sector.
Frequently Asked Questions
What is the SoCalBio Investor & Partnership Conference?
The SoCalBio Investor & Partnership Conference is an annual event featuring leading voices in the bioscience field, aimed at connecting entrepreneurs with investors and strategic partners.
Who will deliver keynote speeches at the conference?
Keynotes will be delivered by Murthy Simhambhatla, PhD, and Raymond W. Cohen, both recognized leaders in the MedTech industry.
What topics will be covered at the conference?
The conference will include startup presentations, investor panels, and discussions on workforce development and technology transfer.
How does SoCalBio support local companies?
SoCalBio helps local firms access capital, partnerships, and essential business support services, fostering growth in the bioscience sector.
Why is international collaboration important in MedTech?
International collaboration is crucial as it facilitates knowledge sharing and opens new markets, enhancing innovation and growth opportunities for companies.
